New drug CAN016 takes on advanced cancers in first human trial
Disease control
Recruiting now
This study tests a new drug, CAN016, in people with advanced solid tumors that have not responded to standard treatments. The trial has two phases: first, finding a safe dose, and second, seeing if the drug shrinks tumors. About 90 participants will receive CAN016 every three wee…
Phase: PHASE1, PHASE2 • Sponsor: Canwell Biotech Limited • Aim: Disease control
Last updated Jul 02, 2026 02:00 UTC